美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=ABACAVIR SULFATE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
ABACAVIR SULFATE 078742 001 ANDA ABACAVIR SULFATE TABLET; ORAL 300MG No 2007/04/05 (TA) MATRIX LABS None (Tentative Approval)
ABACAVIR SULFATE 022293 001 NDA ABACAVIR SULFATE TABLET; ORAL 60MG No 2008/09/12 (TA) AUROBINDO PHARMA None (Tentative Approval)
ABACAVIR SULFATE; LAMIVUDINE 022295 001 NDA ABACAVIR SULFATE; LAMIVUDINE TABLET; ORAL 60MG; 30MG No 2008/12/19 (TA) AUROBINDO PHARMA LTD None (Tentative Approval)
ABACAVIR SULFATE; LAMIVUDINE 090519 001 ANDA ABACAVIR SULFATE; LAMIVUDINE TABLET; ORAL 600MG; 300MG No 2009/03/30 (TA) MATRIX LABS LTD None (Tentative Approval)
ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE 090309 001 ANDA ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE TABLET; ORAL EQ 300MG BASE; 150MG; 300MG No 2009/07/15 (TA) MYLAN PHARMA None (Tentative Approval)
ABACAVIR SULFATE 200733 001 NDA ABACAVIR SULFATE TABLET; ORAL 60 MG TBD 2010/11/29 (TA) MATRIX LABS LTD None (Tentative Approval)
ABACAVIR SULFATE 078348 001 ANDA ABACAVIR SULFATE SOLUTION; ORAL 20MG No 2011/02/16 (TA) CIPLA LIMITED None (Tentative Approval)
ABACAVIR SULFATE 022547 001 NDA ABACAVIR SULFATE TABLET; ORAL 60MG No 2011/03/04 (TA) CIPLA LIMITED None (Tentative Approval)
ABACAVIR SULFATE; LAMIVUDINE 202007 001 NDA ABACAVIR SULFATE; LAMIVUDINE TABLET, FOR SUSPENSION; ORAL 60MG; 30MG No 2011/05/12 (TA) CIPLA LIMITED None (Tentative Approval)
ABACAVIR SULFATE; LAMIVUDINE 202381 001 NDA ABACAVIR SULFATE; LAMIVUDINE TABLET; ORAL 60MG; 30MG No 2012/01/31 (TA) MYLAN LABS None (Tentative Approval)
ABACAVIR SULFATE 091294 001 ANDA ABACAVIR SULFATE TABLET;ORAL EQ 300MG BASE No No 2012/06/18 2012/06/18 MYLAN PHARMS INC Prescription
ABACAVIR SULFATE 077844 001 ANDA ABACAVIR SULFATE TABLET;ORAL EQ 300MG BASE No No 2012/12/17 2012/12/17 AUROBINDO PHARMA LTD Prescription
ABACAVIR SULFATE 201570 001 ANDA ABACAVIR SULFATE TABLET;ORAL EQ 300MG BASE No No 2012/12/17 2012/12/17 APOTEX INC Prescription
ABACAVIR SULFATE 091560 001 ANDA ABACAVIR SULFATE TABLET;ORAL EQ 300MG BASE No No 2013/09/13 2013/09/13 HETERO LABS LTD III Prescription
ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE 202912 001 ANDA ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE TABLET;ORAL EQ 300MG BASE;150MG;300MG No No 2013/12/05 2013/12/05 LUPIN LTD Prescription
ABACAVIR SULFATE; LAMIVUDINE 205412 001 ANDA ABACAVIR SULFATE;LAMIVUDINE TABLET;ORAL 600;300MG No 2014/09/25 (TA) HETERO LABS LTD V None (Tentative Approval)
ABACAVIR SULFATE 201107 001 ANDA ABACAVIR SULFATE SOLUTION;ORAL EQ 20MG BASE/ML No No 2016/09/26 2016/09/26 HETERO LABS LTD III Prescription
ABACAVIR SULFATE AND LAMIVUDINE 079246 001 ANDA ABACAVIR SULFATE; LAMIVUDINE TABLET;ORAL EQ 600MG BASE;300MG No No 2016/09/29 2016/09/29 TEVA PHARMS USA Prescription
ABACAVIR SULFATE 091050 001 ANDA ABACAVIR SULFATE TABLET;ORAL EQ 300MG BASE No No 2016/10/28 2016/10/28 STRIDES PHARMA Prescription
ABACAVIR SULFATE AND LAMIVUDINE 091144 001 ANDA ABACAVIR SULFATE; LAMIVUDINE TABLET;ORAL EQ 600MG BASE;300MG No No 2017/03/28 2017/03/28 CIPLA Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2019 DrugFuture->U.S. FDA Drugs Database